NNV-029

N/A

Report date: 2025/01/26 16:02:30

Base Information

Drug NameNNV-029
Drug Alias Namehumanized anti-CD37 antibody (Nordic Nanovector)NNV-029
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionLeukocyte antigen CD37 antagonists
TargetsLeukocyte antigen CD37
Therapy Area/IndicationsAutoimmune DiseasesHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorway
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNordic Nanovector Asa
China Registration ClassN/A

Develop Information

Active CompaniesNordic Nanovector Asa
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A